Insider Transactions in Q2 2025 at Trans Medics Group, Inc. (TMDX)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 27
2025
|
Edward M Basile |
SELL
Open market or private sale
|
Direct |
5,000
-63.56%
|
$630,000
$126.45 P/Share
|
|
May 27
2025
|
Edward M Basile |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+38.86%
|
$0
$0.7 P/Share
|
|
May 23
2025
|
David Weill |
SELL
Open market or private sale
|
Direct |
732
-5.69%
|
$90,036
$123.88 P/Share
|
|
May 22
2025
|
Thomas James Gunderson |
BUY
Grant, award, or other acquisition
|
Direct |
2,134
+34.46%
|
-
|
|
May 22
2025
|
Merilee Raines |
BUY
Grant, award, or other acquisition
|
Direct |
2,134
+34.46%
|
-
|
|
May 22
2025
|
James R Tobin |
BUY
Grant, award, or other acquisition
|
Direct |
2,134
+34.46%
|
-
|
|
May 22
2025
|
Stephanie Lovell |
BUY
Grant, award, or other acquisition
|
Direct |
2,134
+34.46%
|
-
|
|
May 22
2025
|
Edward M Basile |
BUY
Grant, award, or other acquisition
|
Direct |
2,134
+42.68%
|
-
|
|
May 22
2025
|
David Weill |
BUY
Grant, award, or other acquisition
|
Direct |
2,134
+14.23%
|
-
|
|
May 22
2025
|
Edwin M Kania Jr |
BUY
Grant, award, or other acquisition
|
Direct |
2,134
+0.81%
|
-
|
|
May 09
2025
|
Edward M Basile |
SELL
Open market or private sale
|
Direct |
6,000
-89.13%
|
$690,000
$115.63 P/Share
|
|
May 09
2025
|
Edward M Basile |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+47.13%
|
$0
$0.7 P/Share
|